These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 11171045

  • 1. Tunicamycin induces ubiquitination and degradation of apolipoprotein B in HepG2 cells.
    Liao W, Chan L.
    Biochem J; 2001 Feb 01; 353(Pt 3):493-501. PubMed ID: 11171045
    [Abstract] [Full Text] [Related]

  • 2. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum.
    Liao W, Yeung SC, Chan L.
    J Biol Chem; 1998 Oct 16; 273(42):27225-30. PubMed ID: 9765244
    [Abstract] [Full Text] [Related]

  • 3. Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein.
    Zhou M, Fisher EA, Ginsberg HN.
    J Biol Chem; 1998 Sep 18; 273(38):24649-53. PubMed ID: 9733761
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Apolipoprotein B, a paradigm for proteins regulated by intracellular degradation, does not undergo intracellular degradation in CaCo2 cells.
    Liao W, Chan L.
    J Biol Chem; 2000 Feb 11; 275(6):3950-6. PubMed ID: 10660549
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells.
    Liao W, Chang BH, Mancini M, Chan L.
    J Cell Biochem; 2003 Aug 01; 89(5):1019-29. PubMed ID: 12874835
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48.
    Lindén D, Lindberg K, Oscarsson J, Claesson C, Asp L, Li L, Gustafsson M, Borén J, Olofsson SO.
    J Biol Chem; 2002 Jun 21; 277(25):23044-53. PubMed ID: 11925428
    [Abstract] [Full Text] [Related]

  • 17. Efficient glycosylation site utilization by intracellular apolipoprotein B. Implications for proteasomal degradation.
    Huang XF, Shelness GS.
    J Lipid Res; 1999 Dec 21; 40(12):2212-22. PubMed ID: 10588947
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Demonstration of biphasic effects of docosahexaenoic acid on apolipoprotein B secretion in HepG2 cells.
    Wu X, Shang A, Jiang H, Ginsberg HN.
    Arterioscler Thromb Vasc Biol; 1997 Nov 21; 17(11):3347-55. PubMed ID: 9409332
    [Abstract] [Full Text] [Related]

  • 20. Presecretory degradation of apolipoprotein [a] is mediated by the proteasome pathway.
    White AL, Guerra B, Wang J, Lanford RE.
    J Lipid Res; 1999 Feb 21; 40(2):275-86. PubMed ID: 9925657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.